How to optimize PCI in CKD

Many patients with CAD present with CKD and these patients have a significant increased risk of CV mortality due to CIN. At the ACC2021 Virtual Innovation Stage, Dr. Ziad Ali and Dr. Jai Radhakrishnan discussed these patients and the challenges in diagnosis and treatment of CAD alongwith a variety of tools, techniques and insight that may help facilitate less risky PCI.



September 2, 2021

Created by

Philips Image Guided Therapy Devices Academy

Related presenters

Ziad Ali, MD, DPhil

Ziad Ali, MD, DPhil

Director, DeMatteis Cardiovascular Institute
Director, Investigational Interventional Cardiology
Director of Cardio-Nephrology
St Francis Hospital & Heart Center
Roslyn, NY

Dr. Ali specializes in percutaneous coronary and peripheral vascular interventions.

Jai Radhakrishnan, MD, MBBS, MS, FASN, BRCU

Jai Radhakrishnan, MD, MBBS, MS, FASN, BRCU

Professor of Medicine
Columbia University Medical Center
Clinical Chief, Nephrology Division
New York Presbyterian Hospital
New York, NY, USA

Dr. Radhakrishnan is Professor of Medicine at Columbia University Medical Center. He is the Director of Clinical Services of the Nephrology Division. His clinical and research interests are the in the therapy of chronic kidney disease.